← Stocks · LIMNW page
Price chart & company basics · Trifecta Signals
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
The Trifecta List
Liminatus has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.
That’s the whole record for this stock: the chart and the basics above, and nothing to grade.
The list is the public track record: every stock that has signaled, logged, confirmed, and graded.
Liminatus Pharma trades under the LIMNW ticker, and this page follows its share price and record.
Price history on this page reaches back to October 2026.
The stock closed Tuesday, November 3 at $0.04, unchanged on the day. The last five sessions span about $0.04 to about $0.04.
